Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice

Published:2007-02-02 Issue:1 Volume:10 Page:23-34
ISSN:0969-6970
Container-title:Angiogenesis
language:en
Short-container-title:Angiogenesis

Author:

Bequet-Romero Mónica,Ayala Marta,Acevedo Boris E.,Rodríguez Ernesto Galbán,López Ocejo Omar,Torrens Isis,Gavilondo Jorge V.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Biochemistry,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10456-006-9062-9.pdf

Reference41 articles.

1. Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29:15–18

2. Folkman J (2003) Angiogenesis and apoptosis. Semin Cancer Biol 13:159–167

3. Ohm JE, Carbone DP (2001) VEGF as a mediator of tumor-associated immunodeficiency. Immunol Res 23:263–272

4. Ferrara N, Gerber HP, Lecouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669–676

5. Ferrara N, Hillan KJ, Novotny W (2005) Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys Res Commun 333:328–335

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccines targeting angiogenesis in melanoma;European Journal of Pharmacology;2021-12

2. Specific active immunotherapy with the HEBERSaVax VEGF-based cancer vaccine: From bench to bedside;Seminars in Oncology;2018-01

3. Immunogenicity and efficacy of a rationally designed vaccine against vascular endothelial growth factor in mouse solid tumor models;Cancer Immunology, Immunotherapy;2016-11-21

4. Mannan-modified adenovirus targeting TERT and VEGFR-2: A universal tumour vaccine;Scientific Reports;2015-06-18

5. Specific active immunotherapy with a VEGF vaccine in patients with advanced solid tumors. Results of the CENTAURO antigen dose escalation phase I clinical trial;Vaccine;2014-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3